Postes actifs de Michael A. Byrne
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Directeur Financier/CFO | 01/01/2000 | - |
| Secrétaire Général | 01/01/2000 | - |
Historique de carrière de Michael A. Byrne
Anciens postes connus de Michael A. Byrne
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Canada | 3 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
- Bourse
- Insiders
- Michael A. Byrne
- Expérience
